Skip to main content
Premium Trial:

Request an Annual Quote

ZenBio Licenses Metabolic Cell Line from Harvard

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ZenBio today said that it has licensed rights from Harvard University to become a commercial source for the murine 3T3-L1 cell line for use in metabolic research.

The cell line is derived from 3T3 cells and is used in research on adipose tissue, making it popular for metabolic disease research studies, said the Research Triangle park, NC-based firm. It added that the cell line is recognized as a "very well-characterized, consistent in vitro system, and has served as the basis for a wide range of published studies."

ZenBio will offer the cell lines in low-passage cryopreserved and cultured forms, and it will also offer contract research services tailored to the 3T3-L1 in vitro system. Those services will include assay development, compound screening, conditioned media delivery, gene-expression profiling and further 3T3-L1 characterization. ZenBio also plans to offer metabolic research kits to measure various outputs from 3T3-L1 assays.

Terms of the license were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.